NEW YORK (Reuters Health) – The latest U.S. Preventive Services Task Force lung cancer screening recommendations, issued in March, boost the number of eligible individuals by lowering age and cigarette pack requirements, but lack of insurance coverage means many are unlikely to benefit, researchers say. “Disparities in cancer care are nothing new,” Dr. Gerard Silvestri […]
Home »
Air Pollution ― Second Leading Cause of Lung Cancer
Air pollution is the second leading cause of lung cancer in the world, after smoking, results of a novel analysis suggest. The researchers call for concerted action. The new data show that the rate of lung cancer deaths attributable to air pollution varies widely between countries. Serbia, Poland, China, Mongolia, and Turkey are among the […]
Metformin Disappoints in Two Phase 2 Lung Cancer Trials
Although well tolerated, metformin does not improve survival when given alongside chemoradiotherapy to patients with locally advanced non–small cell lung cancer (NSCLC), and may even make survival worse, suggest results from two recent phase 2 trials. Epidemiologic studies have suggested that metformin is associated with a reduced incidence of cancer, while retrospective case studies have […]
NLR May Be Tied to Survival in Patients With NSCLC Brain Metastases
NEW YORK (Reuters Health) – In patients with non-small cell lung cancer brain metastases (NSCLCBM) treated with immune-checkpoint inhibitors (ICIs) and upfront steroids, a low neutrophil-to-lymphocyte ratio (NLR) was associated with lower overall survival in a single-center retrospective analysis. “With widespread implementation of ICIs for treatment of NSCLC, many clinicians have concerns that the immunosuppressive […]